Table 1.
Demographic and clinical details of the three participant groups
| Variable | DOC (n=10) | Non-DOC (n=13) | Controls (n=12) | Comparison | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Mean | SD | Range | Mean | SD | Range | Mean | SD | Range | p-value | |
| Age (years)1 | 42.70 | 9.75 | 27–55 | 43.92 | 7.29 | 29–51 | 43.67 | 9.13 | 27–55 | 0.942 |
| Gender2 | male=9/female=1 | male=13/female=0 | male=11/female=1 | 0.527 | ||||||
| Handedness3 | 0.764 | 0.29 | 0.07–1.00 | 0.830 | 0.09 | 0.65–1.00 | 0.740 | 0.23 | 0.13–1.00 | 0.560 |
| Premorbid IQ4 | 97.38 | 12.2 | 81–116 | 98.64 | 18.3 | 63–115 | 103.0 | 5.56 | 98–115 | 0.649 |
| Parental socioeconomic status5 | 4.00 | 0.500 | 3–5 | 2.67 | 0.99 | 1–4 | 3.50 | 1.38 | 1–5 | 0.023* |
| Age-of-Onset6 | 23.40 | 4.09 | 18–32 | 22.92 | 3.23 | 18–29 | - | 0.757 | ||
| Medication (CPZ equivalent)7 | 545.4 | 424 | 0–1200 | 444.9 | 304 | 0–1250 | - | 0.523 | ||
| SAPS total8 | 11.00 | 3.77 | 5–17 | 7.231 | 1.17 | 0–13 | - | 0.038* | ||
| SANS total9 | 13.80 | 4.18 | 7–20 | 10.23 | 1.70 | 0–18 | - | 0.129 | ||
*
p < 0.05 for between-group comparison (1-way ANOVA)